A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.
Clinical trial NCT04836858 · COMPLETED
Trial details
- NCT number
- NCT04836858
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-07-14
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.